glp-1 physiology informs the pharmacotherapy of obesity Oral Treatment by and Its Analogs Frontiers | Revisiting food addiction

PMC 20026

Key Benefits of Fasting & GLP-1 Micro-Dosing 1 Supports Weight Loss & Metabolism Fasting enhances fat-burning by switching the body into a fat-adapted state , while GLP-1 micro-dosing helps regulate hunger and energy expenditure

Conservative combination protocol (if attempting) Rationale for conservative approach: No safety data available Both peptides slow gastric emptying significantly Risk of severe GI complications Start low, go slow principle Tirzepatide component: Follow standard FDA-approved titration Weeks 1-4: 2.5mg weekly Weeks 5-8: 5mg weekly Weeks 9-12: 7.5mg weekly Weeks 13-16: 10mg weekly Week 17+: 12.5mg weekly (or stay at 10mg) Some reach 15mg weekly (maximum) Cagrilintide component (reduced from standard): Start AFTER tirzepatide stabilized at therapeutic dose (week 13+) Week 13-16: 0.6mg weekly (lower than standard) Week 17-20: 1.2mg weekly Week 21-24: 1.8mg weekly (may be maximum tolerable) Consider 2.4mg only if tolerating perfectly Conservative dosing comparison: Why sequential is safer: Tirzepatide establishes baseline first Can attribute new side effects to cagrilintide Easier to manage one variable at a time Option to stop cagrilintide if intolerable Less overwhelming than both simultaneously Expected benefits: 18-25% total weight loss (conservative estimate) Potentially superior to tirzepatide alone (15-22%) But incremental benefit may be modest (3-5% additional) Use SeekPeptides to plan sequential peptide additions safely

The patient was managed as an ambulatory basis with wide spectrum antibiotics, improving the clinical course

If your vitamin B12 levels are consistently low, your prescriber may recommend a prescription form of vitamin B12 to raise your levels to a normal range

4-OH (4-hydroxyestrone) metabolite The 4-OH estrone metabolite is again the result of processing by liver enzymes